State-of-the-art immunotherapies may show great promise in the future for cancer treatment.
Immunotherapy research results show that cancer treatment may need a combination approach. Dr. Andrew S. Chi, the chief of neuro-oncology and the codirector of the Brain Tumor Center at NYU Langone, weighed in on the state of developed immunotherapy approaches. A number of strategies involve increasing T-cell activation against tumors by the use of checkpoint inhibitors (that block proteins that inhibit immune system attack of cancer cells). Dr. Chi points out that combinations of immune checkpoint inhibitors may be more effective.